Avicanna (TSX:AVCN) Buildings And Improvements : C$1.53 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Avicanna Buildings And Improvements?

Avicanna's quarterly buildings and improvements declined from Mar. 2024 (C$1.64 Mil) to Jun. 2024 (C$1.55 Mil) and declined from Jun. 2024 (C$1.55 Mil) to Sep. 2024 (C$1.53 Mil).

Avicanna's annual buildings and improvements declined from Dec. 2021 (C$2.20 Mil) to Dec. 2022 (C$1.33 Mil) but then increased from Dec. 2022 (C$1.33 Mil) to Dec. 2023 (C$1.60 Mil).

Avicanna Buildings And Improvements Historical Data

The historical data trend for Avicanna's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Buildings And Improvements Chart

Avicanna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

5.73

5.60

2.20

1.33

1.60

Avicanna Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Buildings And Improvements	Get a 7-Day Free Trial															1.56	1.60	1.64	1.55	1.53

Avicanna Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Avicanna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

AVCNF:USA 0NN:Germany

Address

480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2

Website

https://www.avicanna.com

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Executives

Sheldon Inwentash	10% Security Holder
Threed Capital Inc.	10% Security Holder
Phillip Cardella	Senior Officer
Aras Azadian	Director, Senior Officer
Davender Sohi	Senior Officer
David White	Director
Kyle Lawrence Langstaff	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Chandra Panchal	Director
Janet Giesselman	Director

Avicanna Headlines

No Headlines